Clostridium difficile infection vaccines
Jan 30, 2023
Innovative Vaccines for Clostridium difficile Infection Treatment in the Horizon
Clostridium difficile infection (CDI) has emerged as a significant nosocomial infection over the years with increased incidence, recurrence and need for hospitalization. About 15% to 30% of patients who initially respond to antimicrobial therapy experience recurrent CDI (rCDI). After the first recurrence, the risk ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
